WOEMA CME Webinar Pyrethroid Pesticides: 12-10-2009

It will only take a few minutes to complete the questionnaire and by doing so, you are eligible to receive CME credit (WOEMA members only.) We greatly appreciate your time and input.

CREDIT: WOEMA is accredited by the Institute of Medical Quality/California Medical Association to provide continuing medical education for physicians. WOEMA takes responsibility fo the content, quality, and scientific integrity of this CME activity. WOEMA designates this educational activity when combined with completion and submission of the on-line questionnaire, for a maximum of .40 AMA PRA Category 1 Credit(s). CME certificates are issued to those who successfully participate and complete three (3) webinars to receive a total of 2 AMA PRA Category 1 Credits(s)™. Certificates will be e-mailed to participants on a quarterly basis upon completion of three webinars.

Question Title

* 1. Pyrethroid pesticides are used for the following:

a. Agricultural and structural pest control

b. “Disinsection” of aircraft for international travel

c. Treatment of lice and scabies

d. Weed control

e. a, b, and c

Question Title

* 2. Increased use of pyrethroid pesticides is associated with:

a. Decreased use of organophosphate pesticides

b. A decrease in pyrethroid-related calls to poison control centers

c. Widespread exposure in the US population as measured by urine metabolites

d. a and c

Question Title

* 3. All of the following are true except:

a. Diagnosis of pyrethroid illness in the clinic setting is primarily based on a good occupational and environmental history.

b. Urine metabolite tests should be obtained on all patients to confirm suspected

pyrethroid illness.

c. Cholinesterase tests are not indicated for diagnosis of illness due to pyrethroid pesticides.

d. Topical vitamin E cream may alleviate paresthesias due to pyrethroid pesticides.

Question Title

* 4. Health effects that have been associated with pyrethroid pesticides include:

a. Skin, eye, and upper respiratory tract irritation

b. Non-specific effects such as headache, dizziness, and nausea

c. Reproductive and developmental toxicity

d. Carcinogenicity

e. All of the above

Question Title

* 5. Thank you for completing the questionaire. In order to receive your CME credit for this webinar, please list your name, phone number and email address below.